
Epileptologist

No OPD information available
Epilepsy
Genetic Epilepsy with Febrile Seizures Plus (GEFS+)
Absence Seizure
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
Epilepsy Juvenile Absence
Generalized Tonic-Clonic Seizure
Myoclonic Epilepsy
Partial Familial Epilepsy
Seizures
Conversion Disorder
Cortical Dysplasia
Dravet Syndrome
Epilepsy in Children
Epilepsy with Myoclonic-Atonic Seizures
Hyperventilation
Juvenile Myoclonic Epilepsy
Maffucci Syndrome
Mosaicism
Movement Disorders
Ollier Disease
Photosensitive Epilepsy
Tuberous Sclerosis
Tuberous Sclerosis Complex
West Syndrome
Saul A. Mullen is a male doctor who helps people with different types of epilepsy like Genetic Epilepsy with Febrile Seizures Plus, Absence Seizure, and many more. He also treats conditions like Conversion Disorder, Movement Disorders, and Tuberous Sclerosis.
Dr. Mullen is skilled in treating epilepsy in children and uses special techniques to help patients with seizures. He is known for his caring and understanding way of talking to patients, which makes them trust him.
To stay updated with the latest medical knowledge, Dr. Mullen reads research papers and attends conferences. This helps him provide the best care for his patients.
Dr. Mullen works well with other medical professionals, sharing knowledge and collaborating on treatment plans. His relationships with colleagues ensure that patients receive comprehensive care.
Through his work, Dr. Mullen has positively impacted many patients' lives by improving their health and quality of life. He is dedicated to finding new treatments and techniques to help those with epilepsy and related conditions.
One of Dr. Mullen's notable publications is about a genetic variant causing developmental and epileptic encephalopathy. He has also been involved in a clinical trial studying the effectiveness of a new medication for epilepsy.
In summary, Dr. Saul A. Mullen is a compassionate and knowledgeable doctor who specializes in treating epilepsy and related disorders. His dedication to his patients and commitment to staying informed on the latest medical advancements make him a trusted and valuable healthcare provider.
Enrollment Status: Completed
Published: February 03, 2021
Intervention Type: Drug
Study Drug:
Study Phase: Phase 2
